Analyses with the bulk-seq database suggest that high expression of RNF115 is correlated with poor prognosis in gastric, ovarian and breast cancers, adrenocortical carcinoma, acute myeloid leukemia and kidney chromophobe (51, 59). This evidence concerns the gene RNF115 and breast cancer.